VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/39288291/

⇱ Patient Consent and The Right to Notice and Explanation of AI Systems Used in Health Care - PubMed

Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

Given the need for enforceable guardrails for artificial intelligence (AI) that protect the public and allow for innovation, the U.S. Government recently issued a Blueprint for an AI Bill of Rights which outlines five principles of safe AI design, use, and implementation. One in particular, the right to notice and explanation, requires accurately informing the public about the use of AI that impacts them in ways that are easy to understand. Yet, in the healthcare setting, it is unclear what goal the right to notice and explanation serves, and the moral importance of patient-level disclosure. We propose three normative functions of this right: (1) to notify patients about their care, (2) to educate patients and promote trust, and (3) to meet standards for informed consent. Additional clarity is needed to guide practices that respect the right to notice and explanation of AI in healthcare while providing meaningful benefits to patients.

Keywords: AI policy; Artificial intelligence; consent; patient-centered; regulation; trust.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE STATEMENT

No potential conflict of interest was reported by the author(s).

Comment in

References

    1. AI Act | Shaping Europe’s digital future. 2024, April 30. https://digital-strategy.ec.europa.eu/en/policies/regulatory-framework-ai
    1. Ahn JC, Connell A, Simonetto DA, Hughes C, and Shah VH. 2021. Application of artificial intelligence for the diagnosis and treatment of liver diseases. Hepatology (Baltimore, Md.) 73 (6):2546–63. doi: 10.1002/hep.31603. - DOI - PubMed
    1. Ahn JS, Shin S, Yang S-A, Park EK, Kim KH, Cho SI, Ock C-Y, and Kim S. 2023. Artificial intelligence in breast cancer diagnosis and personalized medicine. Journal of Breast Cancer 26 (5):405–35. doi: 10.4048/jbc.2023.26.e45. - DOI - PMC - PubMed
    1. Amann J, Blasimme A, Vayena E, Frey D, and Madai VI. 2020. Explainability for artificial intelligence in healthcare: A multidisciplinary perspective. BMC Medical Informatics and Decision Making 20 (1):310. doi: 10.1186/s12911-020-01332-6. - DOI - PMC - PubMed
    1. Andreotta AJ, Kirkham N, and Rizzi M. 2022. AI, big data, and the future of consent. AI & Society 37 (4):1715–28. doi: 10.1007/s00146-021-01262-5. - DOI - PMC - PubMed

MeSH terms

Grants and funding

LinkOut - more resources

Full text links
Free PMC article
Cite
Send To

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.